Author Question: Ken's mother was diagnosed with bipolar disorder. Dean's father was diagnosed with depression. Which ... (Read 52 times)

tth

  • Hero Member
  • *****
  • Posts: 579
Ken's mother was diagnosed with bipolar disorder. Dean's father was diagnosed with depression. Which of the following is true?
 
  a) Ken is at higher risk than Dean of developing depression.
  b) Dean is at higher risk than Ken of developing depression.
  c) Dean is at higher risk than Ken of developing bipolar disorder.
  d) It's impossible to predict whether Ken or Dean will develop either disorder.

Question 2

A problem with studies on the link between psychological factors and physical health has been:
 
  a) A general inability of respondents to report physical problems.
  b) Overreporting of physical illness among individuals with high neuroticism.
  c) Underreporting of physical illness among individuals with high psychoticism.
  d) The non-uniform nature of physical illness and associated psychological distress.



ndhahbi

  • Sr. Member
  • ****
  • Posts: 390
Answer to Question 1

a

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The highest suicide rate in the United States is among people ages 65 years and older. Almost 15% of people in this age group commit suicide every year.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library